Transcend's physician-led peptide therapy: licensed clinicians build personalized peptide protocols from a medical intake and lab work, within a broader hormone and metabolic optimization program. Any prescription requires a clinical evaluation.
Some peptides have observational or mechanistic support in humans (e.g., growth hormone-releasing peptides on muscle mass, collagen peptides on joint health), and several have RCT data in specific populations. However, the category is heterogeneous—most peptides lack rigorous human trials, and many marketed peptides (BPC-157, TB-500, AOD-9604) have only preclinical or anecdotal evidence. Regulatory status varies; many are not FDA-approved for the claimed uses and are sold off-label or as research chemicals.
Peptides are short chains of amino acids that can act as signaling molecules, hormones, or growth factors. Depending on the specific peptide, they may modulate immune function, promote tissue repair, enhance cellular communication, or influence metabolic pathways. The mechanism varies widely by peptide type (e.g., BPC-157 may promote angiogenesis and reduce inflammation; TB-500 may enhance actin regulation and wound healing).
EOD publishes opinions and summaries of research about supplements, services, and protocols. It is not medical advice. Consult a qualified healthcare provider before changing your supplement, exercise, sleep, or medication regimen.
Some outbound links on EOD are affiliate links. If you buy through them we may earn a small commission, at no extra cost to you. It never influences what we publish or how it's ranked. Full disclosure.
EOD · 123 Placeholder Street, New York, NY 10001
May be an affiliate link.
Observational
“IMPORTANCE: Obesity has become a global public health concern and China has the largest number of affected people worldwide.”
“Collaborators: MacKinnon I, Zaidman C, Romeo A, Vico M, Abalos F, Sassone S, Aizenberg D, Majul C, Lanchiotti P, Sessa H, Chertkoff A, Waitman J, Dominguez A, Montaña O, Nardone L, Fretes J, Sicer M, Frechtel G, Serra L, Gutnisky L, Maldona”
“BACKGROUND: In acquired thrombotic thrombocytopenic purpura (TTP), an immune-mediated deficiency of the von Willebrand factor-cleaving protease ADAMTS13 allows unrestrained adhesion of von Willebrand factor multimers to platelets and microt”
“BACKGROUND/AIMS: Botulinum toxin A (BTX-A) is an inhibitor of muscular contractions in both striated and smooth muscle.”
The term 'peptide therapy' encompasses hundreds of distinct compounds with vastly different evidence profiles. Most peptides marketed for anti-aging, recovery, or longevity lack human RCTs. Bioavailability is a major concern—many peptides are degraded by stomach acid or proteases, limiting oral efficacy; injection or intranasal routes are often required but less studied in humans. Quality control and purity vary widely in the supplement and research-chemical markets. Regulatory oversight is minimal for many peptides sold outside pharmaceutical channels. Long-term safety data in humans is sparse.
0 comments
Join the conversation. Members can comment, verify, and save finds. Free.
Sign in to comment